Christine Stewart

CellFor is the world's leading independent supplier of high technology seedlings to the global forest industry. Using plant biotechnology, which is the use of biological processes to manufacture products, CellFor identifies and produces genetically superior conifer seedlings without genetic modification. It's not a position they have earned by being the biggest seedling producer in the world, but by being the first to tap into the promise of plant biotechnology to mass produce high quality, top performing conifer seedlings more quickly, more dependably, and in far greater quantities than ever before. CellFor corporate headquarters is based in Vancouver, British Columbia, with the primary research and development, laboratory and production facilities located north of Victoria, on Vancouver Island. They have more than 200 scientists and technicians at their facilities in and around Victoria, where they are producing somatic embryos and seedlings on a commercial scale for customers in North America, South America and Australasia. In addition, CellFor has a Sales and Marketing team located in Atlanta, Georgia.

Isotechnika, Inc. operates as an international biopharmaceutical company. The firm discovers and develops immunosuppressive therapeutic drugs for treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. The company is headquartered in Edmonton, Canada.

Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada